Gastrointestinal Diseases  >>  NGC-capecitabine (PCS6422)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00004195: Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer

Completed
2
28
US
eniluracil, 5 Fu/eniluracil (eli Lilly), 5-fu/eniluracil, 5fu/eniluraci, conventional colon surgery
University of Alabama at Birmingham, National Cancer Institute (NCI), Glaxo Wellcome
Colorectal Cancer
10/99
05/01
NCT00005050: Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer

Completed
1/2
US
ethynyluracil, fluorouracil, oxaliplatin
NYU Langone Health, National Cancer Institute (NCI)
Colorectal Cancer
06/01
 

Download Options